In addition, this study analyzed the relationship between serum miR-106 and MYL4 and the risk stratification of thromboembolism in AF and found that with the increase of CHA2DS2 score, the level of serum miR-106 was increased, and the level of MYL4 was decreased. This evidence concerns the gene MYL4 and atrial fibrillation.